FDA seeks additional safety data from Eli Lilly for Foundayo to assess cardiovascular, liver, thyroid, and pediatric risks post-approval.

Google is investing an additional $9 billion in data centers in Virginia. This is supposed to be treated as good news – that we’re going to get more of these electricity hogs and environment killers ...

Beam Therapeutics Inc. (BEAM) is gearing up to release four abstracts at the upcoming American Society of Hematology [ASH] annual meeting in 2024. The thing is that the company notes in its earnings ...

Nuvectis Pharma (NVCT) had a bit of a problem back in November of 2024 because that's when its stock traded lower by as much as 45% when it released data from its phase 1b study using NXP800 for the ...

July 31 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab said on Wednesday that additional data on patients, beyond what was initially identified, had been stolen in a cyberattack and ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals ...

PALO ALTO, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...